Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
RETRACTED: Evidence for Other Non-Poliovirus Enteroviruses Multiplies in L20B Cells.

Clinical and vaccine immunology : CVI

Sarmiento L, Más P, Palomera R, Morier L, Fonseca M, Resik S.
PMID: 17360852
Clin Vaccine Immunol. 2007 May 10; doi: 10.1128/CVI.00017-06. Epub 2007 May 10.

This article has been retracted.

Cite
Sarmiento L, Más P, Palomera R, et al. RETRACTED: Evidence for Other Non-Poliovirus Enteroviruses Multiplies in L20B Cells. Clin Vaccine Immunol. 2007;doi: 10.1128/CVI.00017-06.
Sarmiento, L., Más, P., Palomera, R., Morier, L., Fonseca, M., & Resik, S. (2007). RETRACTED: Evidence for Other Non-Poliovirus Enteroviruses Multiplies in L20B Cells. Clinical and vaccine immunology : CVI, . https://doi.org/10.1128/CVI.00017-06
Sarmiento, Luis, et al. "RETRACTED: Evidence for Other Non-Poliovirus Enteroviruses Multiplies in L20B Cells." Clinical and vaccine immunology : CVI vol. (2007). doi: https://doi.org/10.1128/CVI.00017-06
Sarmiento L, Más P, Palomera R, Morier L, Fonseca M, Resik S. RETRACTED: Evidence for Other Non-Poliovirus Enteroviruses Multiplies in L20B Cells. Clin Vaccine Immunol. 2007 May 10; doi: 10.1128/CVI.00017-06. Epub 2007 May 10. PMID: 17360852.
Copy Download .nbib Format: NLM
Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva.

Clinical and vaccine immunology : CVI

[No authors listed]
PMID: 20357076
Clin Vaccine Immunol. 2010 Apr;17(4):698. doi: 10.1128/CVI.00092-10.

No abstract available.

Cite
Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Vaccine Immunol. 2010;17(4):698doi: 10.1128/CVI.00092-10.
(2010). Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clinical and vaccine immunology : CVI, 17(4), 698. https://doi.org/10.1128/CVI.00092-10
"Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva." Clinical and vaccine immunology : CVI vol. 17,4 (2010): 698. doi: https://doi.org/10.1128/CVI.00092-10
Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Vaccine Immunol. 2010 Apr;17(4):698. doi: 10.1128/CVI.00092-10. PMID: 20357076; PMCID: PMC2849331.
Copy Download .nbib Format: NLM
Correction for Nishimori et al., “Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis”.

Clinical and vaccine immunology : CVI

Nishimori A, Konnai S, Okagawa T, Maekawa N, Goto S, Ikebuchi R, Nakahara A, Chiba Y, Ikeda M, Murata S, Ohashi K.
PMID: 29741849
Clin Vaccine Immunol. 2018 Apr 17;24(12). doi: 10.1128/CVI.00001-18. Print 2017 Dec.

No abstract available.

Cite
Nishimori A, Konnai S, Okagawa T, et al. Correction for Nishimori et al., “Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis”. Clin Vaccine Immunol. 2018;24(12)doi: 10.1128/CVI.00001-18.
Nishimori, A., Konnai, S., Okagawa, T., Maekawa, N., Goto, S., Ikebuchi, R., Nakahara, A., Chiba, Y., Ikeda, M., Murata, S., & Ohashi, K. (2017). Correction for Nishimori et al., “Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis”. Clinical and vaccine immunology : CVI, 24(12), . https://doi.org/10.1128/CVI.00001-18
Nishimori, Asami, et al. "Correction for Nishimori et al., “Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis”." Clinical and vaccine immunology : CVI vol. 24,12 (2017). doi: https://doi.org/10.1128/CVI.00001-18
Nishimori A, Konnai S, Okagawa T, Maekawa N, Goto S, Ikebuchi R, Nakahara A, Chiba Y, Ikeda M, Murata S, Ohashi K. Correction for Nishimori et al., “Identification of an Atypical Enzootic Bovine Leukosis in Japan by Using a Novel Classification of Bovine Leukemia Based on Immunophenotypic Analysis”. Clin Vaccine Immunol. 2018 Apr 17;24(12). doi: 10.1128/CVI.00001-18. Print 2017 Dec. PMID: 29741849.
Copy Download .nbib Format: NLM
Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp.

Clinical and vaccine immunology : CVI

Goldblatt D, McKeen A, Burbidge P, McElhiney S, McLaughlin L, Johnson A, Rauh M, Giardina PC.
PMID: 28724524
Clin Vaccine Immunol. 2017 Sep 05;24(9). doi: 10.1128/CVI.00194-17. Print 2017 Sep.

The pneumococcal enzyme-linked immunosorbent assay (ELISA) reference standard serum, lot 89SF, had been in use since 1990 and was replaced with a new reference standard serum, 007sp, in 2013. This serum was generated under an FDA-approved clinical protocol where...

Cite
Goldblatt D, McKeen A, Burbidge P, et al. Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp. Clin Vaccine Immunol. 2017;24(9)doi: 10.1128/CVI.00194-17.
Goldblatt, D., McKeen, A., Burbidge, P., McElhiney, S., McLaughlin, L., Johnson, A., Rauh, M., & Giardina, P. C. (2017). Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp. Clinical and vaccine immunology : CVI, 24(9), . https://doi.org/10.1128/CVI.00194-17
Goldblatt, D, et al. "Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp." Clinical and vaccine immunology : CVI vol. 24,9 (2017). doi: https://doi.org/10.1128/CVI.00194-17
Goldblatt D, McKeen A, Burbidge P, McElhiney S, McLaughlin L, Johnson A, Rauh M, Giardina PC. Assignment of Weight-Based Antibody Units for Four Additional Serotypes to a Human Antipneumococcal Standard Reference Serum, 007sp. Clin Vaccine Immunol. 2017 Sep 05;24(9). doi: 10.1128/CVI.00194-17. Print 2017 Sep. PMID: 28724524; PMCID: PMC5585694.
Copy Download .nbib Format: NLM
N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate.

Clinical and vaccine immunology : CVI

Lee SM, Wu CK, Plieskatt JL, Miura K, Hickey JM, King CR.
PMID: 28747311
Clin Vaccine Immunol. 2017 Oct 05;24(10). doi: 10.1128/CVI.00140-17. Print 2017 Oct.

Transmission-blocking vaccines have the potential to accelerate malaria parasite elimination by inducing antibodies that block parasite transmission from humans to mosquitoes. Pfs230, a gametocyte surface protein involved in gamete function, has long been a promising candidate. Due to the...

Cite
Lee SM, Wu CK, Plieskatt JL, et al. N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate. Clin Vaccine Immunol. 2017;24(10)doi: 10.1128/CVI.00140-17.
Lee, S. M., Wu, C. K., Plieskatt, J. L., Miura, K., Hickey, J. M., & King, C. R. (2017). N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate. Clinical and vaccine immunology : CVI, 24(10), . https://doi.org/10.1128/CVI.00140-17
Lee, Shwu-Maan, et al. "N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate." Clinical and vaccine immunology : CVI vol. 24,10 (2017). doi: https://doi.org/10.1128/CVI.00140-17
Lee SM, Wu CK, Plieskatt JL, Miura K, Hickey JM, King CR. N-Terminal Pfs230 Domain Produced in Baculovirus as a Biological Active Transmission-Blocking Vaccine Candidate. Clin Vaccine Immunol. 2017 Oct 05;24(10). doi: 10.1128/CVI.00140-17. Print 2017 Oct. PMID: 28747311; PMCID: PMC5629673.
Copy Download .nbib Format: NLM
Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model.

Clinical and vaccine immunology : CVI

Vianzon V, Illek B, Moe GR.
PMID: 28794055
Clin Vaccine Immunol. 2017 Oct 05;24(10). doi: 10.1128/CVI.00188-17. Print 2017 Oct.

Capsular polysaccharide-protein conjugate vaccines protect individuals from invasive disease and decrease carriage, which reduces spread of the organism in the population. In contrast, antibodies elicited by plain polysaccharide or protein antigen-based meningococcal (Men) vaccines have little or no effect...

Cite
Vianzon V, Illek B, Moe GR. Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model. Clin Vaccine Immunol. 2017;24(10)doi: 10.1128/CVI.00188-17.
Vianzon, V., Illek, B., & Moe, G. R. (2017). Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model. Clinical and vaccine immunology : CVI, 24(10), . https://doi.org/10.1128/CVI.00188-17
Vianzon, Vianca, et al. "Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model." Clinical and vaccine immunology : CVI vol. 24,10 (2017). doi: https://doi.org/10.1128/CVI.00188-17
Vianzon V, Illek B, Moe GR. Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model. Clin Vaccine Immunol. 2017 Oct 05;24(10). doi: 10.1128/CVI.00188-17. Print 2017 Oct. PMID: 28794055; PMCID: PMC5629670.
Copy Download .nbib Format: NLM
Validation of an immunochromatographic assay for the multiple detection of specific antibodies against HIV, HBV, and HCV.

Clinical and vaccine immunology : CVI

[No authors listed]
PMID: 23100481
Clin Vaccine Immunol. 2013 Jan;20(1):128. doi: 10.1128/CVI.00485-12. Epub 2012 Nov 15.

No abstract available.

Cite
Validation of an immunochromatographic assay for the multiple detection of specific antibodies against HIV, HBV, and HCV. Clin Vaccine Immunol. 2012;20(1):128doi: 10.1128/CVI.00485-12.
(2013). Validation of an immunochromatographic assay for the multiple detection of specific antibodies against HIV, HBV, and HCV. Clinical and vaccine immunology : CVI, 20(1), 128. https://doi.org/10.1128/CVI.00485-12
"Validation of an immunochromatographic assay for the multiple detection of specific antibodies against HIV, HBV, and HCV." Clinical and vaccine immunology : CVI vol. 20,1 (2013): 128. doi: https://doi.org/10.1128/CVI.00485-12
Validation of an immunochromatographic assay for the multiple detection of specific antibodies against HIV, HBV, and HCV. Clin Vaccine Immunol. 2013 Jan;20(1):128. doi: 10.1128/CVI.00485-12. Epub 2012 Nov 15. PMID: 23100481; PMCID: PMC3535778.
Copy Download .nbib Format: NLM
Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine.

Clinical and vaccine immunology : CVI

Sarkadi J, Jankovics M, Fodor K, Kis Z, Takacs M, Visontai I, Jankovics I, Gonczol E.
PMID: 26104762
Clin Vaccine Immunol. 2015 Jul;22(7):844. doi: 10.1128/CVI.00243-15.

No abstract available.

Cite
Sarkadi J, Jankovics M, Fodor K, et al. Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine. Clin Vaccine Immunol. 2015;22(7):844doi: 10.1128/CVI.00243-15.
Sarkadi, J., Jankovics, M., Fodor, K., Kis, Z., Takacs, M., Visontai, I., Jankovics, I., & Gonczol, E. (2015). Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine. Clinical and vaccine immunology : CVI, 22(7), 844. https://doi.org/10.1128/CVI.00243-15
Sarkadi, Julia, et al. "Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine." Clinical and vaccine immunology : CVI vol. 22,7 (2015): 844. doi: https://doi.org/10.1128/CVI.00243-15
Sarkadi J, Jankovics M, Fodor K, Kis Z, Takacs M, Visontai I, Jankovics I, Gonczol E. Correction for Sarkadi et al., High-Level Cellular and Humoral Immune Responses in Guinea Pigs Immunized Intradermally with a Heat-Inactivated Varicella-Zoster Virus Vaccine. Clin Vaccine Immunol. 2015 Jul;22(7):844. doi: 10.1128/CVI.00243-15. PMID: 26104762; PMCID: PMC4478531.
Copy Download .nbib Format: NLM
Correction for Bekkering et al., ".

Clinical and vaccine immunology : CVI

Bekkering S, Blok BA, Joosten LAB, Riksen NP, van Crevel R, Netea MG.
PMID: 28476732
Clin Vaccine Immunol. 2017 May 05;24(5). doi: 10.1128/CVI.00096-17. Print 2017 May.

No abstract available.

Cite
Bekkering S, Blok BA, Joosten LAB, et al. Correction for Bekkering et al., ". Clin Vaccine Immunol. 2017;24(5)doi: 10.1128/CVI.00096-17.
Bekkering, S., Blok, B. A., Joosten, L. A. B., Riksen, N. P., van Crevel, R., & Netea, M. G. (2017). Correction for Bekkering et al., ". Clinical and vaccine immunology : CVI, 24(5), . https://doi.org/10.1128/CVI.00096-17
Bekkering, Siroon, et al. "Correction for Bekkering et al., "." Clinical and vaccine immunology : CVI vol. 24,5 (2017). doi: https://doi.org/10.1128/CVI.00096-17
Bekkering S, Blok BA, Joosten LAB, Riksen NP, van Crevel R, Netea MG. Correction for Bekkering et al., ". Clin Vaccine Immunol. 2017 May 05;24(5). doi: 10.1128/CVI.00096-17. Print 2017 May. PMID: 28476732; PMCID: PMC5424232.
Copy Download .nbib Format: NLM
Alloreactivity and association of human natural killer cells with the major histocompatibility complex.

Clinical and vaccine immunology : CVI

[No authors listed]
PMID: 18391189
Clin Vaccine Immunol. 2008 Apr;15(4):735. doi: 10.1128/CVI.00095-08.

No abstract available.

Cite
Alloreactivity and association of human natural killer cells with the major histocompatibility complex. Clin Vaccine Immunol. 2008;15(4):735doi: 10.1128/CVI.00095-08.
(2008). Alloreactivity and association of human natural killer cells with the major histocompatibility complex. Clinical and vaccine immunology : CVI, 15(4), 735. https://doi.org/10.1128/CVI.00095-08
"Alloreactivity and association of human natural killer cells with the major histocompatibility complex." Clinical and vaccine immunology : CVI vol. 15,4 (2008): 735. doi: https://doi.org/10.1128/CVI.00095-08
Alloreactivity and association of human natural killer cells with the major histocompatibility complex. Clin Vaccine Immunol. 2008 Apr;15(4):735. doi: 10.1128/CVI.00095-08. PMID: 18391189; PMCID: PMC2292647.
Copy Download .nbib Format: NLM
A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.

Clinical and vaccine immunology : CVI

Murphy TF, Brauer AL, Johnson A, Wilding GE, Koszelak-Rosenblum M, Malkowski MG.
PMID: 28659326
Clin Vaccine Immunol. 2017 Sep 05;24(9). doi: 10.1128/CVI.00130-17. Print 2017 Sep.

No abstract available.

Cite
Murphy TF, Brauer AL, Johnson A, et al. A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease. Clin Vaccine Immunol. 2017;24(9)doi: 10.1128/CVI.00130-17.
Murphy, T. F., Brauer, A. L., Johnson, A., Wilding, G. E., Koszelak-Rosenblum, M., & Malkowski, M. G. (2017). A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease. Clinical and vaccine immunology : CVI, 24(9), . https://doi.org/10.1128/CVI.00130-17
Murphy, Timothy F, et al. "A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease." Clinical and vaccine immunology : CVI vol. 24,9 (2017). doi: https://doi.org/10.1128/CVI.00130-17
Murphy TF, Brauer AL, Johnson A, Wilding GE, Koszelak-Rosenblum M, Malkowski MG. A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease. Clin Vaccine Immunol. 2017 Sep 05;24(9). doi: 10.1128/CVI.00130-17. Print 2017 Sep. PMID: 28659326; PMCID: PMC5585693.
Copy Download .nbib Format: NLM
Insights from natural infection-derived immunity to cholera instruct vaccine efforts.

Clinical and vaccine immunology : CVI

Pasetti MF, Levine MM.
PMID: 22993412
Clin Vaccine Immunol. 2012 Nov;19(11):1707-11. doi: 10.1128/CVI.00543-12. Epub 2012 Sep 19.

No abstract available.

Cite
Pasetti MF, Levine MM. Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol. 2012;19(11):1707-11doi: 10.1128/CVI.00543-12.
Pasetti, M. F., & Levine, M. M. (2012). Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clinical and vaccine immunology : CVI, 19(11), 1707-11. https://doi.org/10.1128/CVI.00543-12
Pasetti, Marcela F, and Levine, Myron M. "Insights from natural infection-derived immunity to cholera instruct vaccine efforts." Clinical and vaccine immunology : CVI vol. 19,11 (2012): 1707-11. doi: https://doi.org/10.1128/CVI.00543-12
Pasetti MF, Levine MM. Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol. 2012 Nov;19(11):1707-11. doi: 10.1128/CVI.00543-12. Epub 2012 Sep 19. PMID: 22993412; PMCID: PMC3491553.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries